LexisNexis will be offering a webinar on "The Next Billion-Dollar Acquisition in Pharma -- A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene" on February 11, 2019 at 2:00 pm (ET). Gene Quinn of IPWatchdog and Kevin Noonan of Patent Docs will take a look at the recently announced merger between Bristol-Myers Squibb and Celgene, including what the combined company will look like from a patent perspective, and what competition regulators are likely to be interested in questioning about this acquisition.
Those interested in registering for the webinar, can do so here.
Comments